Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giorgio Natali

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|March 2, 2006
Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasisDomenico Vitolo, Luciano Ciocci, Gloria Deriu, et al.
Journal of Translational Medicine|July 30, 2015
Prognostic relevance of LGALS3BP in human colorectal carcinomaEnza Piccolo, Nicola Tinari, Domenica D'Addario, et al.
The Lancet. Oncology|May 5, 2012
Melanoma molecular classes and prognosis in the postgenomic eraElisa Tremante, Agnese Ginebri, Elisa Lo Monaco, et al.
Journal of Cellular Physiology|July 28, 2011
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implicationsLuana Calabrò, Luca Sigalotti, Ester Fonsatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumorsFrancesca Di Modugno, Marcella Mottolese, Anna Di Benedetto, et al.
Oncotarget|June 26, 2014
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic processSilvia Grassilli, Federica Brugnoli, Rossano Lattanzio, et al.
Preventive Medicine|July 20, 2010
Skin cancer risk factors among primary school children: investigations in Western HungaryKatalin Fehér, Maria Cecilia Cercato, Ida Prantner, et al.
Cancer Research|September 9, 2010
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patientsBelinda Palermo, Duilia Del Bello, Alessandra Sottini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapyClaudio Botti, Simonetta Buglioni, Maria Benevolo, et al.
Journal of Cellular Physiology|December 29, 2004
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancerMarcella Mottolese, Edit A Nádasi, Claudio Botti, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|March 2, 2006
Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasisDomenico Vitolo, Luciano Ciocci, Gloria Deriu, et al.
Journal of Translational Medicine|July 30, 2015
Prognostic relevance of LGALS3BP in human colorectal carcinomaEnza Piccolo, Nicola Tinari, Domenica D'Addario, et al.
The Lancet. Oncology|May 5, 2012
Melanoma molecular classes and prognosis in the postgenomic eraElisa Tremante, Agnese Ginebri, Elisa Lo Monaco, et al.
Journal of Cellular Physiology|July 28, 2011
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implicationsLuana Calabrò, Luca Sigalotti, Ester Fonsatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumorsFrancesca Di Modugno, Marcella Mottolese, Anna Di Benedetto, et al.
Oncotarget|June 26, 2014
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic processSilvia Grassilli, Federica Brugnoli, Rossano Lattanzio, et al.
Preventive Medicine|July 20, 2010
Skin cancer risk factors among primary school children: investigations in Western HungaryKatalin Fehér, Maria Cecilia Cercato, Ida Prantner, et al.
Cancer Research|September 9, 2010
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patientsBelinda Palermo, Duilia Del Bello, Alessandra Sottini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapyClaudio Botti, Simonetta Buglioni, Maria Benevolo, et al.
Journal of Cellular Physiology|December 29, 2004
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancerMarcella Mottolese, Edit A Nádasi, Claudio Botti, et al.
Pageof 10